OTCMKTS:OXBDF Oxford BioMedica (OXBDF) Stock Price, News & Analysis $7.35 0.00 (0.00%) As of 11/13/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and TrendsShort Interest About Oxford BioMedica Stock (OTCMKTS:OXBDF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Oxford BioMedica alerts:Sign Up Key Stats Today's Range$7.35▼$7.3550-Day Range$5.83▼$7.6552-Week Range$5.80▼$12.61Volume30,000 shsAverage Volume12,545 shsMarket Capitalization$778.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Oxford BioMedica is a contract development and manufacturing organization focused on cell and gene therapies. The company works with biotechnology and pharmaceutical companies to develop and manufacture viral vectors and other materials used in advanced therapies, supporting programs from early development through commercial production. Its capabilities include lentiviral, adeno-associated viral and adenoviral vector technologies, along with process development, analytical testing and manufacturing services. Oxford BioMedica was founded in 1995 and initially developed its own gene and cell therapy candidates before building its business around services for other companies. Headquartered in the United Kingdom, Oxford BioMedica serves customers internationally and has expanded its operations in Europe through acquisitions, including ABL Europe. Its chief executive officer is Frank Mathias.AI Generated. May Contain Errors. Read More Receive OXBDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioMedica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OXBDF Stock News HeadlinesOxford BioMedica's AI tools could cut development time by 80%, Jefferies saysOctober 23, 2026 | proactiveinvestors.comOxford Biomedica Adds LTIP Shares to London ListingOctober 9, 2026 | tipranks.comThis is likely to EXPLODEDr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.November 14 at 1:00 AM | Weiss Ratings (Ad)Oxford Biomedica reports RSU exercise and share sale by senior US executiveOctober 6, 2026 | tipranks.comAnalysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Oxford BioMedica (OXBDF)October 1, 2026 | theglobeandmail.comOxford Biomedica director boosts stake with share purchaseSeptember 25, 2026 | tipranks.comOxford BioMedica (OXBDF) Gets a Buy from RBC CapitalSeptember 25, 2026 | theglobeandmail.comOxford Biomedica plc (OXBDF) Q2 2026 Earnings Call TranscriptSeptember 24, 2026 | seekingalpha.comSee More Headlines OXBDF Stock Analysis - Frequently Asked Questions How have OXBDF shares performed this year? Oxford BioMedica's stock was trading at $8.15 at the beginning of 2026. Since then, OXBDF stock has decreased by 9.8% and is now trading at $7.35. How do I buy shares of Oxford BioMedica? Shares of OXBDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Oxford BioMedica own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford BioMedica investors own include Oxford Biomedica (OXB), NVIDIA (NVDA), Delta Air Lines (DAL), Mastercard (MA), Rio Tinto (RIO), Hummingbird Resources (HUM) and Lloyds Banking Group (LLOY). Company Calendar Today11/14/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:OXBDF Previous SymbolNASDAQ:OXBDF CIKN/A Webwww.oxfordbiomedica.co.uk Phone44-18-6578-3000FaxN/AEmployees891Year Founded1995Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$164.59 million Price / Sales4.73 Cash FlowN/A Price / Cash FlowN/A Book Value$0.62 per share Price / Book11.85Miscellaneous Outstanding Shares105,960,000Free FloatN/AMarket Cap$778.81 million OptionableNot Optionable Beta1.24 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:OXBDF) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioMedica Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioMedica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
